ARCHIVES

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Nelvis Castro To Serve As Acting OCC Chief; HHS Selects ANA President Malone.

January 7, 2000

Pauling Contends His Applications Included Essentials

April 27, 1979

14th Cancer Congress Big Success; CICA Satellite Established; US, USSR Renew Cancer Agreement

September 12, 1986

List of FY97 SPORE Grantees and Their Awards

December 12, 1997

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

April 5, 2002

In Brief: UICC Honors Dodd; Centers Recognize Nealon; Tale Expands Transplant Program

March 28, 1997